MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer

Authors :: Jens Huober
Olivier Tredan
G.G. Jaliffe
A. Di Leo
S-C Chen
T. Forrester
Matthew P. Goetz
Susana Barriga
Luis Manso
Shani Paluch-Shimon
Nawel Bourayou
In Hae Park
Martin Frenzel
M. Campone
Ian C. Smith
Orit Freedman
M. Toi
Joohyuk Sohn
Source :: Annals of Oncology. 28:v609
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Advanced breast
Cancer
Hematology
medicine.disease
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
Internal medicine
Medicine
030212 general & internal medicine
business
Initial therapy
Abemaciclib

Tools